| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 162.07M | 166.14M | 195.19M | 214.17M | 206.15M |
| Gross Profit | 61.63M | 66.65M | 60.19M | 61.06M | 59.04M |
| EBITDA | 9.72M | -1.32M | 26.80M | -10.73M | 11.24M |
| Net Income | 2.19M | -4.74M | -29.10M | -14.50M | 4.19M |
Balance Sheet | |||||
| Total Assets | 145.11M | 138.50M | 139.76M | 202.65M | 210.82M |
| Cash, Cash Equivalents and Short-Term Investments | 6.17M | 8.20M | 8.06M | 1.91M | 3.56M |
| Total Debt | 72.11M | 74.82M | 70.14M | 67.87M | 42.75M |
| Total Liabilities | 114.19M | 121.39M | 121.94M | 142.01M | 123.32M |
| Stockholders Equity | 30.93M | 17.11M | 17.83M | 60.64M | 86.97M |
Cash Flow | |||||
| Free Cash Flow | 1.10M | 3.55M | -11.55M | -25.99M | -3.40M |
| Operating Cash Flow | 2.09M | 8.37M | -10.46M | -20.79M | 4.62M |
| Investing Cash Flow | -9.74M | -4.72M | 20.85M | 891.00K | -12.59M |
| Financing Cash Flow | 10.19M | -8.00M | -4.14M | 20.29M | 6.03M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £462.83M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
70 Outperform | £122.12M | 5.94 | 15.34% | 1.71% | 3.48% | 318.89% | |
69 Neutral | £51.97M | 18.48 | 17.89% | 0.77% | 14.64% | 916.67% | |
68 Neutral | £165.37M | 37.63 | 5.22% | 0.80% | 22.80% | -32.13% | |
65 Neutral | £322.84M | 52.26 | 7.57% | 1.04% | 10.93% | 12.30% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | £90.13M | 42.76 | 10.33% | ― | -14.23% | 97.27% |